• XPO1 Inhibition by Eltanexor Modulates Wnt/β-Catenin in CRC

  2026-05-09

  This study demonstrates that Eltanexor (KPT-8602), a second-generation XPO1 inhibitor, reduces colorectal cancer tumorigenesis by modulating the Wnt/β-catenin signaling pathway and lowering COX-2 expression. The findings highlight the compound's chemopreventive efficacy and mechanistic specificity in preclinical CRC models, providing a foundation for translational cancer therapeutics targeting nuclear export.

• Regulatory Gene Cross-Talk Enhances A40926 Antibiotic Produc

  2026-05-08

  This study reveals that heterologous expression of certain StrR-like regulatory genes can boost the biosynthetic output of glycopeptide antibiotics such as A40926 in producing actinobacteria. By demonstrating functional cross-talk between distantly related biosynthetic gene clusters, the research offers new strategies for activating silent antibiotic pathways and optimizing fermentation yields.

• UPF3A Is Ubiquitously Expressed Across Mouse Tissues: NMD Im

  2026-05-08

  This study overturns previous assumptions by demonstrating that the NMD factor UPF3A is not restricted to male germlines but is expressed at comparable or even higher levels than UPF3B in most mouse tissues. These findings refine our understanding of NMD regulation and suggest broader roles for UPF3A in tissue homeostasis and gene expression control.

• Alternative Splicing Orchestrates TRIM46 Expression in Axono

  2026-05-07

  This study uncovers how alternative splicing, mRNA surveillance, and protein stability converge to control the temporal and neuron-specific expression of TRIM46 during axon formation. The findings clarify molecular checkpoints in axonogenesis, offering a mechanistic blueprint for studying developmental gene regulation.

• Cy5-UTP: Optimizing RNA Labeling for FISH & Expression Array

  2026-05-07

  Cy5-UTP (Cyanine 5-UTP) from APExBIO enables streamlined, high-sensitivity RNA probe synthesis for fluorescence in situ hybridization and dual-color expression arrays. Discover how protocol fine-tuning and evidence-driven optimization unlock robust, reproducible fluorescent RNA labeling at scale.

• Efficacy of Antiseptics and Antibiotics in Burn Care: Insigh

  2026-05-06

  This Cochrane review systematically evaluates the comparative effectiveness of antiseptics versus topical antibiotics in burn wound management, focusing on wound healing, infection control, and patient safety. The findings refine understanding of optimal antimicrobial approaches, highlighting knowledge gaps and practical considerations for translational research.

• CBD Attenuates Orofacial Inflammatory Pain via Cannabinoid P

  2026-05-06

  This study demonstrates that cannabidiol (CBD) robustly reduces both sensory and affective dimensions of orofacial inflammatory pain in mice, acting through peripheral and central endocannabinoid mechanisms. These results highlight the translational potential of CBD for comprehensive pain management and provide a mechanistic foundation for future endocannabinoid-targeted research.

• Recombinant Human Oncostatin M (E.coli, Tag Free, Lyophilize

  2026-05-05

  This article guides biomedical researchers through practical challenges in cell viability and proliferation assays, emphasizing the robustness and reproducibility of Recombinant Human Oncostatin M (E.coli, Tag Free, Lyophilized) (SKU P1045). Supported by quantitative specifications and scenario-driven analysis, it demonstrates how this tag-free, E.coli-expressed cytokine offers superior sensitivity and workflow confidence for demanding experimental designs.

• EZ Cap™ Cas9 mRNA (m1Ψ): Precision Genome Editing Enhanced

  2026-05-05

  EZ Cap™ Cas9 mRNA (m1Ψ) unlocks efficient, immune-evasive CRISPR-Cas9 editing in mammalian cells by leveraging advanced Cap1 capping and m1Ψ modifications. This solution empowers researchers with high-fidelity, reproducible workflows and actionable troubleshooting strategies, setting a new benchmark for mRNA-based genome engineering.

• CAFs Mediate Chemoresistance in Prostate Cancer via ANGPTL4-

  2026-05-04

  This study elucidates how cancer-associated fibroblasts (CAFs) drive chemoresistance in prostate cancer by promoting mitochondrial biogenesis and oxidative phosphorylation through the ANGPTL4-IQGAP1 signaling axis. Integrating proteomics, metabolomics, and functional inhibition, the findings reveal actionable metabolic and signaling targets for overcoming prostate cancer drug resistance.

• BIBR 1532: Advanced Telomerase Inhibition and Novel Synergy

  2026-05-04

  Explore how BIBR 1532, a potent telomerase inhibitor, uniquely impacts cancer cell proliferation and apoptosis. This article delivers a deeper scientific analysis and integrates recent findings on telomere attrition, setting it apart from standard reviews.

• Ademetionine in Neurological Disorders: Methylation Insights

  2026-05-03

  This review synthesizes evidence on the role of ademetionine (S-adenosylmethionine, SAMe) as a crucial methyl donor in central nervous system (CNS) function and pathology. The article highlights SAMe's impact on methylation reactions, neurotransmitter metabolism, and its clinical potential in treating neuropsychiatric disorders such as depression and dementia.

• Proteinase K in Fungal Pathogenesis and DNA Purity Assurance

  2026-05-02

  Explore how Proteinase K, a broad-spectrum serine protease, advances both genomic DNA isolation and fungal pathogen research. Discover unique insight into its mechanistic precision and practical impact for complex biological workflows.

• circ_0042103/TAF15/NER Axis Modulates DNA Damage in Pulpitis

  2026-05-01

  This study identifies the circ_0042103/TAF15/NER regulatory axis as a key driver of DNA damage and inflammation in human dental pulp stem cells during pulpitis. By elucidating how circular RNA impairs nucleotide excision repair, the research advances understanding of inflammatory dental disease pathogenesis and suggests new molecular targets for future therapeutic development.

• Dabigatran: Advances in Oral Anticoagulation for Thromboembo

  2026-05-01

  This article reviews the landmark innovations and evidence supporting dabigatran, a direct thrombin inhibitor, for the prevention and treatment of thromboembolic disorders. The study delineates its pharmacological advantages over vitamin K antagonists, discusses safety, and highlights implications for translational cardiovascular research.

14780 records 1/986 page Next 12345 下5页 Last page